Page last updated: 2024-08-22

pimozide and cyclin d1

pimozide has been researched along with cyclin d1 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cui, Y; Fan, Y; Han, W; He, Q; Hu, S; Jin, J; Li, J; Liu, J; Liu, L; Lv, T; Sun, Y; Yang, Y; Yu, W1
Deng, Q; Li, Z; Liang, J; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K1

Other Studies

2 other study(ies) available for pimozide and cyclin d1

ArticleYear
CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway.
    Scientific reports, 2017, 02-20, Volume: 7

    Topics: CD8-Positive T-Lymphocytes; Cell Line; Cell Proliferation; Chemokine CCL5; Coculture Techniques; Cyclin D1; Dihydrotestosterone; Epithelial Cells; Finasteride; Gene Expression Regulation; Humans; Male; Phosphorylation; Pimozide; Prostatic Hyperplasia; Signal Transduction; STAT5 Transcription Factor

2017
Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl‑xL signaling pathways.
    International journal of molecular medicine, 2021, Volume: 47, Issue:1

    Topics: Animals; bcl-X Protein; Bromocriptine; Cell Line, Tumor; Cyclin D1; Humans; Mice; Mice, Nude; Pimozide; Pituitary Neoplasms; Prolactinoma; Rats; Signal Transduction; STAT5 Transcription Factor; Xenograft Model Antitumor Assays

2021